BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.77% |
| 2 | Financials | 3.07% |
| 3 | Industrials | 1.75% |
| 4 | Healthcare | 1.67% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
NewMarket
NEU
$8.72B
| $179K | ﹤0.01% |
457
-656
| -59% | -$253K |
|
|
CHN
1777
DELISTED
China Fund
CHN
| $179K | ﹤0.01% |
8,450
+100
| +1% | +$2.04K |
|
1778
Kilroy Realty
KRC
$4.3B
| $178K | ﹤0.01% |
2,864
-11,006
| -79% | -$665K |
|
1779
Helen of Troy
HELE
$699M
| $178K | ﹤0.01% |
+2,940
| New | +$183K |
|
1780
Lincoln Electric
LECO
$15.5B
| $176K | ﹤0.01% |
2,515
-5,177
| -67% | -$351K |
|
1781
CALL
Lincoln National
LNC
$8.67B
| $176K | ﹤0.01% |
+1,253
| New | +$61.9K |
|
1782
LXP Industrial Trust
LXP
$3.58B
| $175K | ﹤0.01% |
3,177
+1,634
| +106% | +$90.6K |
|
1783
Workday
WDAY
$51B
| $174K | ﹤0.01% |
1,937
-4,076,095
| -100% | -$321M |
|
|
APC
1784
CALL
DELISTED
Anadarko Petroleum
APC
| $174K | ﹤0.01% |
297
+197
| +197% | +$20.1K |
|
1785
Howard Hughes
HHH
$4.04B
| $174K | ﹤0.01% |
1,156
-2,674
| -70% | -$373K |
|
|
VR
1786
DELISTED
Validus Hold Ltd
VR
| $170K | ﹤0.01% |
4,451
-7,750
| -64% | -$289K |
|
|
AUXL
1787
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $170K | ﹤0.01% |
+8,472
| New | +$194K |
|
1788
CALL
CVS Health
CVS
$121B
| $169K | ﹤0.01% |
1,365
+614
| +82% | +$46.4K |
|
1789
Incyte
INCY
$24.4B
| $169K | ﹤0.01% |
3,000
+881
| +42% | +$45K |
|
1790
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $166K | ﹤0.01% |
+13,705
| New | +$164K |
|
|
TCO
1791
DELISTED
Taubman Centers Inc.
TCO
| $166K | ﹤0.01% |
2,192
-9,662
| -82% | -$711K |
|
|
RXII
1792
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $165K | ﹤0.01% |
53,772
+53,449
| +16,548% | +$164K |
|
|
SVVC
1793
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
| $164K | ﹤0.01% |
7,721
+124
| +2% | +$2.58K |
|
|
HUB.B
1794
DELISTED
HUBBELL INC CL-B
HUB.B
| $164K | ﹤0.01% |
1,331
-3,337
| -71% | -$395K |
|
1795
PUT
Lam Research
LRCX
$422B
| $162K | ﹤0.01% |
15,430
+2,910
| +23% | +$17.4K |
|
|
EMC
1796
PUT
DELISTED
EMC CORPORATION
EMC
| $162K | ﹤0.01% |
9,535
+300
| +3% | +$7.92K |
|
|
SPPP
1797
Sprott Physical Platinum and Palladium Trust
SPPP
$602M
| $162K | ﹤0.01% |
+15,974
| New | +$158K |
|
1798
Pool Corp
POOL
$7.29B
| $160K | ﹤0.01% |
2,836
+139
| +5% | +$8.11K |
|
1799
CALL
iShares MSCI Australia ETF
EWA
$1.45B
| $160K | ﹤0.01% |
+1,750
| New | +$46.2K |
|
1800
Regis Corp
RGS
$70.1M
| $159K | ﹤0.01% |
565
+114
| +25% | +$30.9K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.